S

SalioGen Therapeutics

76 employees

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Inherited disease
Life Science
Therapeutics
Cell therapy
Genetic disease
Genome engineering
Gene therapy
Cell engineering
Genetics

Date founded

2020

Funding rounds raised

Total raised

$115M

from 6 investors over 6 rounds

S

SalioGen Therapeutics raised $115M on January 5, 2022

Investors: GordonMD Global Investments LP, T. Rowe Price, EPIQ, RD Fund and D1 Capital Partners L.P.

S

SalioGen Therapeutics raised $20M on February 18, 2021

Investors: PBM Capital Group

FAQ